This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Immunomedics Inc
IMMU : NASDAQ : Health Care
$3.81 -0.03 | -0.78%
Today's Range: 3.69 - 3.99
Avg. Daily Volume: 505,100
09/30/14 - 11:41 AM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
IMMU IMMUNOMEDICS INC 3.41 317.52 n/m 9.04 82.22
DVAX DYNAVAX TECHNOLOGIES CORP 1.42 373.29 n/m 12.32 21.29
CTIC CTI BIOPHARMA CORP 2.48 371.83 n/m 36.00 2413.96
VNDA VANDA PHARMACEUTICALS INC 10.79 365.54 n/m 37.50 15.03
PGNX PROGENICS PHARMACEUTICAL INC 5.14 357.52 n/m 7.13 -49.20
GERN GERON CORP 2.12 332.59 n/m 1.22 -44.56
RGLS REGULUS THERAPEUTICS INC 7.02 304.61 n/m 13.94 -0.75
RNA PROSENSA HOLDING NV 8.39 302.85 n/m 28.16 954.21
EXEL EXELIXIS INC 1.55 302.42 n/m 21.28 -50.11
CUR NEURALSTEM INC 3.28 284.83 n/m 0.01 -94.99
RTRX RETROPHIN INC 10.60 282.83 n/m 5.77 n/a
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

IMMU Ind Avg S&P 500
n/m 81.36 19.49
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs